Effect of single dose of intravenous heparin on plasma levels of angiogenic growth factors.
Division of Cardiology, Department of Medicine, Duke University and Durham Veteran's Administration Medical Center, Durham, North Carolina 27705, USA.
Mark A
MA
East
Dawn I
DI
Landis
Michael A
MA
Thompson
Brian H
BH
Annex
D000925:Anticoagulants / Q000008:administration & dosage*; D006328:Cardiac Catheterization; D003327:Coronary Disease / Q000378:metabolism / Q000628:therapy; D016228:Endothelial Growth Factors / Q000097:blood*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D016222:Fibroblast Growth Factor 2 / Q000097:blood*; D006493:Heparin / Q000008:administration & dosage*; D006801:Humans; D007275:Injections, Intravenous; D036341:Intercellular Signaling Peptides and Proteins / Q000097:blood*; D008222:Lymphokines / Q000097:blood*; D008297:Male; D008875:Middle Aged; D018919:Neovascularization, Physiologic / Q000187:drug effects; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D000925:Anticoagulants; D016228:Endothelial Growth Factors; D036341:Intercellular Signaling Peptides and Proteins; D008222:Lymphokines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D016222:Fibroblast Growth Factor 2; D006493:Heparin